Video | 15 May 2024 Webinar: Part 2 - Access to GLP-1s (medicines like Ozempic) and SGLT-2s for people living with type 2 diabetes 1 min DIABETES The MSF Access Campaign hosted a webinar on why we need newer medicines to treat people living with type 2 diabetes in low- and middle-income countries, and why people’s access to GLP-1s (eg, Ozempic) may be a major challenge. Read, watch, share Filter by - Any -BlogFeature storyIssue briefPress releaseResearch articleStatementTechnical briefVideo Video Video | 14 May 2024 Diabetes Webinar: Part 1 - Lowering the price of insulin everywhere: let’s make it a reality 1 min Photo credit: Carmen Yahchouchi/MSF Press release Press release | 08 May 2024 Diabetes New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable 6 min Issue brief | 08 May 2024 Diabetes Defeating the Double Standard in Diabetes Care Photo credit: Carmen Yahchouchi/MSF Press release Press release | 27 March 2024 Diabetes New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens 6 min Research article | 27 March 2024 Diabetes JAMA Network Open: Estimated Sustainable Cost-Based Prices for Diabetes Medicines Photograph by Maya Abu Ata Statement Statement | 22 January 2024 Diabetes MSF statement on EB154/7 - Follow up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (NCDs) 1 min Blog Blog | 14 November 2023 Diabetes World Diabetes Day: how insulin pens can improve the lives of people living with diabetes Blog Blog | 10 November 2023 Diabetes DNDi: 20 years of delivering treatments for neglected patients Load More
Video Video | 14 May 2024 Diabetes Webinar: Part 1 - Lowering the price of insulin everywhere: let’s make it a reality 1 min
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 08 May 2024 Diabetes New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable 6 min
Photo credit: Carmen Yahchouchi/MSF Press release Press release | 27 March 2024 Diabetes New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens 6 min
Research article | 27 March 2024 Diabetes JAMA Network Open: Estimated Sustainable Cost-Based Prices for Diabetes Medicines
Photograph by Maya Abu Ata Statement Statement | 22 January 2024 Diabetes MSF statement on EB154/7 - Follow up to the political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases (NCDs) 1 min
Blog Blog | 14 November 2023 Diabetes World Diabetes Day: how insulin pens can improve the lives of people living with diabetes
